04 25 pharma-law-policy-march-2022 2022 Related Topics 
SQA
DECEMBER 16, 2022
SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022. 30 of 2022.
SQA
FEBRUARY 26, 2024
Ltd, a Contract Research Organization (CRO) in Kharadi, India, was subject to a Good Clinical Practice (GCP) inspection in November 2020 and November 2022 by the Spanish Agency for Medicines and Medical Devices (AEMPS). Key findings are as follows: The company lacked systems and processes for handling and evaluating adverse drug reactions.
Expert insights. Personalized for you.
40 
Let's personalize your content